Mycophenolate mofetil is ester of mycophenolic acid with-morpholinoethanol. It is a prodrug and effective to use in organ transplantation. Since the invention and governmental approval, this product is newer, safer and more effective drug to help patient for organ repellant problem.

Since 1995, US FDA approves this drug for using in the kidney transplantation after phase I, II, III wide clinical trail. It now also proves this drug is good for heart, lung, and liver-transplant in addition to kidney transplant patients.It also-reduces the adverse effects on the patients with long-term care problems in health care.From most recent scientific literature, the intensive study in science and medical disciplines, it proves this drug can cure or slow down the destruction of almost all the hyper autoimmune syndrome in human abnormalities, such as SLE, ADRIAMYCIN NEPHROPATHYand many kidney dysfunctiondiseases.Apparently, it works much better than the-previous drugs with similar function such as cyclosporine and steroids.

Start from 1998, this MMF becomes the first choice of newer generation of Immunosuppressant and received high approval from medical sectors.

Jin Hai Pharmaceutical Co. is incorporated with American technology to produce this product in commercial scale with international standard of quality and very competitive price under GMP facilities and disciplines.

The related information and samples as well the commercial terms can be obtained from the company or visit the website of this company.